risks and outcomes of covid-19 infection for patients on immunotherapy
Published 2 years ago • 228 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:38
should cancer patients undergoing immunotherapy get the covid-19 vaccination?
-
15:03
outcomes for immunosuppressed vs non-immunosuppressed cancer patients with covid-19 treated with io
-
1:31
the impact of cancer treatment on covid-19 mortality
-
11:34
covid-19: risk of cancer patients to infection
-
36:51
immunotherapy and the covid-19 pandemic: addressing clinical case challenges in lung cancer
-
4:50
prognostic factors and outcomes of cancer patients with covid-19
-
3:12
impact of covid-19 on cancer care
-
5:59
the medium and long-term impacts of covid-19 on cancer care
-
48:36
covid-19 and cancer immunotherapy research: cancer research institute's live stream event
-
3:15
psychological consequence of covid-19 on cancer patients
-
15:21
the impact of covid-19 on the cancer patient | dr. charu aggarwal
-
6:03
respiratory specialist adrian chan on impact of covid-19 on asthma patients
-
1:40
impact of the covid-19 pandemic on cancer services in the uk
-
1:43
cancer and coronavirus - will immunotherapy be affected?
-
4:55
covid-19-related risk factors in patients with blood cancers
-
2:20
covid-19 virus also increases risk for other infections here is how
-
26:04
what helps against covid-19? | covid-19 special
-
11:58
how long does coronavirus immunity last? | covid-19 special
-
59:07
ask an ms expert – impact of covid-19 on those living with multiple sclerosis